Pfizer, Moderna ask for emergency approval of COVID-19 vaccines in Europe

Pfizer and Moderna have asked for emergency approvals of their COVID-19 vaccine candidates in Europe, the region’s health regulatory agency announced on Tuesday. Both companies filed for conditional marketing authorizations, the European Medicines Agency (EMA) said. The agency said a decision could be issued “within weeks, depending on whether the data submitted are sufficiently robust and complete to show the quality, safety and effectiveness…